from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2650c/-

LFCtreatmentdescriptionclass of inhibitor

0.003

Amikacinug/mL Amikacintranslation

-0.775

Cap5-10ug/mL Capreomycintranslation

-0.055

Rox10-50 ug/mL Roxithromycintranslation

-0.276

SM2-5 ug/mL Streptomycintranslation

-1.028

Tet5-10 ug/mL Tetracyclinetranslation

-0.071

Rif0.2-5ug/mL Rifampicintranscription

-0.375

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.135

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.971

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.331

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.108

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.408

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.654

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.873

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.584

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.396

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.073

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.852

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.575

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.583

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.046

Nigericin50 uM Nigericinrespiration

0.190

TRC10-150 ug/mL Triclosanrespiration

0.918

TRZ10-25 ug/mL Thioridazinerespiration

5.009

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.246

menadione6-10 ug/mL Menadionerespiration

-0.287

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.450

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.606

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.353

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.109

NRP_1Non-replicating persistence stage 1dosRassociated

-0.342

Amp0.2mg/mL AmpicillincellWall

-0.255

Cephalexin20-100 ug/mL CephalexincellWall

-0.459

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.506

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.744

EMB10-20 ug/mL EthambutolcellWall

-0.395

Eta12-40 ug/mL EthionamidecellWall

-0.560

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.425

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.756

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.852

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.405

BZA0.12 mg/mL BenzamidearomaticAmides

-0.043

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.371

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.084

H2O24 mM hydrogen peroxideDNAdamaging

-0.415

Levo10 ug/mL LevofloxacinDNAdamaging

-0.208

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.780

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.504

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.486

UVUV-irradiationDNAdamaging

-0.208

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.628

Antimycin12.5-50 ug/mL Antimycin A?

-0.387

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.100

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.002

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.051

PA8240.2-2 ug/mL PA-824?

1.251

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.194

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.556

Verapamil50 uM Verapamil?

-0.090

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.733

methoxatin10-20 ug/mL Methoxatin?